瑞典查尔姆斯理工大学的研究人员通过蛋白质组学分析发现,即使低密度脂蛋白(LDL)胆固醇水平处于正常范围,富含甘油三酯的脂蛋白(TRL)和脂蛋白(a)(Lp(a))仍可能通过引发炎症及损伤血管壁来增加心脏病发作的风险 1。这项研究揭示了上述脂蛋白颗粒导致心血管疾病的生物学机制,表明其作用独立于传统的胆固醇积累过程 1。
研究人员对血液中近3000种蛋白质进行了测量和分析,发现TRL和Lp(a)携带有能够吸引免疫细胞的蛋白质,这些蛋白质可能促进炎症反应并改变血管壁结构 1。与主要风险源于动脉壁中胆固醇积累的LDL不同,TRL和Lp(a)涉及的是类似的炎症和血管病理过程 1。该成果已发表在《欧洲心脏杂志》上,领导研究者Clemens Wittenbecher强调:“降低LDL胆固醇仍然是预防工作的基石。” 1
Scientists at Chalmers University of Technology in Sweden have identified biological mechanisms that explain why heart attacks can still occur even when low-density lipoprotein (LDL) cholesterol levels are within normal ranges. Through proteomic analysis, the research team discovered that triglyceride-rich lipoproteins (TRL) and lipoprotein(a) [Lp(a)] contribute to cardiovascular risk by triggering inflammation and damaging vessel walls, independent of traditional cholesterol accumulation processes 1. The study highlights that while LDL’s primary risk is associated with cholesterol buildup in arterial walls, TRL and Lp(a) particles involve distinct but overlapping inflammatory and vascular pathways that compromise heart health 1.
The findings, published in the European Heart Journal on November 10, 2026, stem from an extensive analysis measuring nearly 3,000 proteins in blood samples 1. Led by researcher Clemens Wittenbecher with Jakub Morze as the primary author, the study revealed that TRL and Lp(a) carry specific proteins that attract immune cells, potentially promoting inflammation and altering the structure of blood vessel walls 1. Despite these additional risks, the lead investigator emphasized that managing standard lipid profiles remains essential for prevention. "Lowering LDL cholesterol remains a cornerstone of prevention," says Clemens Wittenbecher 1.
评论
还没有评论,欢迎留下第一条。